CV Sciences (CVSI) EBITDA (2011 - 2026)
CV Sciences (CVSI) posted EBITDA of -$318000.0 for Q1 2026, down 324.0% sequentially from -$75000.0 in Q4 2025, and down 2990.91% YoY from $11000.0 in Q1 2025.
CV Sciences (CVSI) EBITDA (2011 - 2026) Analysis & Trends
CV Sciences has reported EBITDA for 16 years, with the latest figure at -$318000.0 in Q1 2026.
- Quarterly EBITDA fell 2990.91% year-over-year to -$318000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$799000.0 (up 48.75% YoY) and the FY2025 annual result came in at -$470000.0, up 78.54% from the prior year.
- EBITDA retreated to -$318000.0 in Q1 2026 per CVSI's latest filing, from -$75000.0 in the prior quarter.
- Over five years, EBITDA peaked at $5.8 million in Q1 2023 and troughed at -$2.3 million in Q2 2022.
- A 5-year average of -$380294.1 and a median of -$583000.0 in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2026: EBITDA soared 480.33% in 2023, then sank 2990.91% in 2026.
- Over 5 years, EBITDA stood at -$2.1 million in 2022, then soared by 58.16% to -$889000.0 in 2023, then advanced by 27.33% to -$646000.0 in 2024, then surged by 88.39% to -$75000.0 in 2025, then tumbled by 324.0% to -$318000.0 in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$318000.0, -$75000.0, and -$275000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | CV Sciences | 4.12 Mn | 3.86 Mn | 1.45 Mn | -301,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -301,000.00 |
| Mar 31, 2026 | -318,000.00 |
| Dec 31, 2025 | -75,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -131,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -646,000.00 |
| Sep 30, 2024 | -341,000.00 |
| Jun 30, 2024 | -583,000.00 |
| Mar 31, 2024 | -620,000.00 |
| Dec 31, 2023 | -889,000.00 |
| Sep 30, 2023 | -437,000.00 |
| Jun 30, 2023 | -1.08 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | -2.13 Mn |
| Sep 30, 2022 | -892,000.00 |
| Jun 30, 2022 | -2.32 Mn |
| Mar 31, 2022 | -1.52 Mn |
| Dec 31, 2021 | -8.84 Mn |
| Sep 30, 2021 | -2.98 Mn |